During the past decade, Christine KATLAMA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Christine KATLAMA" are "HIV Infections" (2 trials) and "Coronavirus Infection" (1 trials). Many other conditions were trialed in "Christine KATLAMA" in a lesser frequency.

Most popular intervention types in "Christine KATLAMA" are "Drug" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "COVID-19 IgG / IgM rapid test (whole blood, serum, plasma)" (1 trials), "DORAVIRINE 100 MG [Pifeltro]" (1 trials) and "Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christine KATLAMA" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Christine KATLAMA". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Christine KATLAMA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Christine KATLAMA, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".